ReLiver: Morphocell's engineered tissue simply explained in its future potential to treat liver disease.
Using advanced tissue engineering, we’re developing the world’s first effective treatments for the most dire liver diseases
Morphocell Technologies to Present at 2023 Biotech Showcase
Morphocell Technologies Announces a New Stem Cell Process that May Pave Way for Liver Cell Therapy and Drug Development
The US Patent Office has granted Morphocell Technologies a first patent for its Encapsulated Liver Tissue platform
Morphocell partners with CQDM and Takeda Pharmaceuticals to support the development of its ReLiver technology
Partnership Advances Large Animal Model Testing